Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1798]
News [2689]
Articles [196]
Editorials [1]
Conferences [135]
elearning [13]
Helping cancer patients avoid excessive radiation
Helping cancer patients avoid excessive radiation
Pembrolizumab combination as a potentially transformative treatment for HER2-positive gastric cancer
Pembrolizumab combination as a potentially transformative treatment for HER2-positive gastric cancer
ASH 2021: Axicabtagene ciloleucel demonstrates potential as first-line therapy for patients with high-risk large B-cell lymphoma
ASH 2021: Axicabtagene ciloleucel demonstrates potential as first-line therapy for patients with high-risk large B...
ASH 2021: ZUMA-7 demonstrates lasting benefits of CAR-T therapy over current standard of care for large B-cell lymphoma
ASH 2021: ZUMA-7 demonstrates lasting benefits of CAR-T therapy over current standard of care for large B-cell...
SABCS 2021: Subgroup analysis of trastuzumab deruxtecan shows ‘encouraging’ results in controlling stable brain metastases in HER2-positive metastatic breast cancer
SABCS 2021: Subgroup analysis of trastuzumab deruxtecan shows ‘encouraging’ results in controlling stable brain...
SABCS 2021: Black women are more likely to develop lymphedema following breast cancer treatment than white women
SABCS 2021: Black women are more likely to develop lymphedema following breast cancer treatment than white women
Connecting the dots to find new treatments for breast cancer
Connecting the dots to find new treatments for breast cancer
SABCS 2021: Investigational therapy pyrotinib with chemotherapy may improve outcomes in patients with pretreated HER2-positive breast cancer
SABCS 2021: Investigational therapy pyrotinib with chemotherapy may improve outcomes in patients with pretreated...
Chemoimmunotherapy dramatically improved survival of high-risk neuroblastoma patients
Chemoimmunotherapy dramatically improved survival of high-risk neuroblastoma patients
Activation of a key protein that allows glioblastoma cells to complete apoptosis
Activation of a key protein that allows glioblastoma cells to complete apoptosis

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation